MedPath

Unequal Placental Sharing in Monochorionic Diamniotic Twins: an Observational Study

Recruiting
Conditions
Monochorionic Twins
Registration Number
NCT03024918
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Brief Summary

This is an observational study in 3 cohorts of monochorionic diamniotic (MCDA) twins. The aim of the study is to assess whether unequal placental sharing can be predicted in pregnancy and whether it is predictive of pregnancy outcome.

Detailed Description

In all cohorts, serial ultrasound will be performed during pregnancy. MRI will be offered once during pregnancy. After delivery, placental examination will be performed.

In unselected MCDA twins, the investigators will assess the relationship between unequal placental sharing and the risk of fetal or neonatal loss. The investigators will also establish whether umbilical vein measurements or MRI can be used to predict placental sharing.

In cases complicated by twin-to-twin transfusion syndrome (TTTS), the investigators will look at the association between unequal placental sharing and intrauterine fetal demise after laser surgery.

In cases complicated by selective intra-uterine growth restriction (sIUGR), the the relationship between unequal placental sharing and the risk of fetal or neonatal loss and birth prior to 34 weeks will be assessed.

Furthermore, data on neurological outcome at 2 years of age in all cohorts will be collected.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
393
Inclusion Criteria
  • MCDA cohort

    • Ongoing monochorionic diamniotic twin pregnancy between 11 and 14 weeks, as determined by the crown rump length of the larger twin in spontaneous conceptions and by the date of insemination or embryonic age at replacement in pregnancies resulting from subfertility treatment
    • Women aged 18 years or more, who are able to consent
    • Written informed consent to participate in this study, forms being approved by the Ethical Committees
  • TTTS cohort

    • Monochorionic diamniotic twin pregnancy, with gestational age defined in the first trimester as mentioned above
    • Complicated by TTTS according to the definition used in the Quintero staging of TTTS (DVP of donor < 2 cm and DVP of receptor > 8 cm before 20 weeks or > 10 cm after 20 weeks
    • Undergoing laser surgery for TTTS
    • Women aged 18 years or more, who are able to consent
    • Written informed consent to participate in this study, forms being approved by the Ethical Committees
  • sIUGR cohort

    • Monochorionic diamniotic twin pregnancy, with gestational age defined in the first trimester as mentioned above
    • Complicated by sIUGR defined as a discordance in EFW of ≥ 20%, with the percentage of discordance being calculated as (EFW larger twin - EFW smaller twin)/EFW larger twin x 100.
    • Women aged 18 years or more, who are able to consent
    • Written informed consent to participate in this study, forms being approved by the Ethical Committees
Exclusion Criteria
  • Age < 18 years
  • Inability to consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MCDA cohort: the association between unequal sharing and risk of fetal or neonatal loss (assessed by review of obstetric and pediatric records)2 weeks after expected date of birth
sIUGR cohort: the association between unequal sharing and risk of fetal or neonatal loss and birth prior to 34 weeks (assessed by review of obstetric and pediatric records)2 weeks after expected date of birth
TTTS cohort: the association between unequal sharing and intrauterine fetal death (assessed by review of obstetric records)2 weeks after expected date of birth
Secondary Outcome Measures
NameTimeMethod
The correlation between prenatal ultrasound and MRI variables and placental sharing as assessed by postnatal imaging (all cohorts)2 weeks after expected date of birth
The association between unequal sharing and intact survival (all cohorts) (assessed by review of obstetric and pediatric records and parent questionnaire)2 years after expected date of birth

Trial Locations

Locations (1)

UZ Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath